Identification Of Novel Inhibitors Of Chorismate Mutase Enzyme Involved In Shikimate Pathway Of Mycobacterium Tuberculosis: Design And In-vitro Screening | 4691
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Identification of novel inhibitors of chorismate mutase enzyme involved in shikimate pathway of Mycobacterium tuberculosis: Design and in-vitro screening

3rd World Congress on Biotechnology

Reshma Chowdary Alokam, Jean kumar, D. Sriram and P.Yogeeswari

Posters: Agrotechnol

DOI: 10.4172/2155-952X.S1.020

Tuberculosis is a frightful disease which affects one third of world population, and kills 1-2 million people a year, is a top health priority. The emergence of multiple and extensively drug resistant forms (MDR and XDR) of the disease that are difficult to treat with the existing drug regimen. Despite this need, no new drug classes have been specifically marketed for TB in the last forty years, in part owing to lengthy and costly process that makes almost two decades for drug approval. One strategy that will allow for a rapid path to new anti-TB agents to discover new classes of compounds against already validated targets. One of the target is Chorismate mutase (E.C, which catalysis conversion of Chorismate to prephenate by claisen rearrangement. This enzymatically catalysed conversion of Chorismate proceed through a endo-oxa bicyclic (chair- like) transition state. Chorismate plays a key role in shikimate pathway for biosynthesis of aromatic amino acids like phenyl alanine, tyrosine and tryptophan. Thus, it has a main role in maintaining the balance between these aromatic amino acids in the cell is vital. In this study, we performed invitro screening of inhouse database molecules. More than 15 molecules showed IC50 below 1micro molar concentration. These were further supported by docking studies using Glide module (schrodinger.Inc). Hence, the thiazine derivative which showed highest percentage of inhibition at 1micromolar conccentration can be a potential lead for treating tuberculosis.
Reshma Chowdary Alokam completed her Microbiology from Avanthi PG College affiliated to Osmania University. Currently she is pursuing her Ph.D from BITS-Pilani Hyderabad Campus, Jawahar Nagar, Hyderabad.